AKZOY vs MOH
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
AKZOY · AKZO NOBEL NV SPON ADS EACH REP 1/3 ORD SHS(R/S)$23.30 ▲ 0.34%
MOH · Molina Healthcare$208.99 ▼ 3.53%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- AKZOY +7.4%
- MOH +48.3%
Head to head
| Metric | AKZOY | MOH |
|---|---|---|
| Price | $23.30 | $208.99 |
| Change today | ▲ 0.34% | ▼ 3.53% |
| Market cap | $10.91B | $10.91B |
| Return, 3 months | -3.2% | +5.1% |
| Return, year to date | +3.6% | +20.4% |
| Return, 1 year | +7.6% | +37.4% |
| P/E (TTM) | 15.9 | -307.3 |
| P/B | 2.2 | 2.6 |
| P/E percentile vs own 5y | – | 0th |
| Dividend yield | 3.30% | – |
| Revenue growth (YoY, latest qtr) | – | -3.4% |
| Net profit growth (YoY) | – | -51.9% |
| Gross margin | – | 8.0% |
| Operating margin | – | 0.6% |
| Net margin | – | -0.1% |
| Return on equity | – | -1.2% |
| Analyst target vs. price | – | +9.1% |
| Analyst buy share | – | 29% |
| RSI (14) | 59 | 52 |
| 30-day volatility | 30.4% | 46.0% |
| Max drawdown, 1 year | -24.6% | -39.2% |
| Trend read | Strong uptrend | Leaning bullish |
| Analyst consensus | – | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- AKZOY is the largest of the group by market value.
- MOH has returned the most over the past year.
- MOH carries the lowest trailing P/E.
- AKZOY has been the calmest stock over the last 30 days.